About the Authors
- Koen M. Marien
-
* E-mail: koen.marien@uantwerpen.be
Affiliations Division of Physiopharmacology, University of Antwerp, Antwerp, Belgium, HistoGeneX NV, Antwerp, Belgium
- Valerie Croons
-
Affiliation HistoGeneX NV, Antwerp, Belgium
- Yannick Waumans
-
Affiliation HistoGeneX NV, Antwerp, Belgium
- Ellen Sluydts
-
Affiliation HistoGeneX NV, Antwerp, Belgium
- Stefanie De Schepper
-
Affiliation HistoGeneX NV, Antwerp, Belgium
- Luc Andries
-
Affiliation HistoGeneX NV, Antwerp, Belgium
- Wim Waelput
-
Affiliation Department of Pathology, University Hospital Brussels (UZ Brussel), Brussels, Belgium
- Erik Fransen
-
Affiliation StatUa Center for Statistics, University of Antwerp, Antwerp, Belgium
- Peter B. Vermeulen
-
Affiliation CORE (Translational Cancer Research Unit, GZA Hospitals), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
- Mark M. Kockx
-
Affiliation HistoGeneX NV, Antwerp, Belgium
- Guido R. Y. De Meyer
-
Affiliation Division of Physiopharmacology, University of Antwerp, Antwerp, Belgium
Competing Interests
The authors have read the journal's policy and the authors of this manuscript have the following competing interests: Koen Marien, Valerie Croons, Yannick Waumans, Ellen Sluydts, Stefanie De Schepper, and Luc Andries are employees of HistoGeneX NV (Antwerp, Belgium). Mark Kockx is CEO of HistoGeneX NV, which carries out immunohistochemical testing for pharmaceutical companies as part of (pre-)clinical studies that evaluate new anticancer drugs. Mark Kockx and Wim Waelput are consulting pathologists to Pathomation BVBA. The authors have no other relevant affiliations or financial involvements with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: KMM SDS LA PBV MMK GRYDM. Performed the experiments: KMM VC YW ES WW PBV. Analyzed the data: EF YW KM. Contributed reagents/materials/analysis tools: MMK. Wrote the paper: KM YW PBV GRYDM.